John E. II Friend
CIK 1704021 · Chief Executive Officer · last filed 2026-07-08
John E. II Friend is a Chief Executive Officer who has filed 5 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for KZIA, was dated Jul 8, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
5
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KZIA | Chief Executive Officer | — | $13.04 | — | $0 | 1 | 2026-07-08 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Chief Medical Officer | 100,000 | $0.12 | $11.9K | $0 | 4 | 2021-03-05 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-08 | KZIA | Grant (A) | — | $0 | EDGAR |
| 2021-03-05 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-10-15 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-18 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.